Feature

Collaboration aims to harness Tevogen’s proprietary immunotherapy platform and Dr. Neal Flomenberg’s expertise in research and the transplantation of T cells

Company announces data from two clinical trials, with a mix of bad and good news

Phesi analysis details the pandemic’s impact on recruitment and the future of trials

Researchers are increasingly targeting autoimmunity rather than hyperglycemia as they search for better ways to treat type 1 diabetes

Encouraging preclinical results demonstrate a strong antibody and cellular immune response and 100-percent protection against SARS-CoV-2 infection following a single vaccination

GlobalData highlights some example of how artificial intelligence systems are handling drug repurposing to find potential COVID-19 therapies

BioSymetrics collaborates with Janssen and Sema4 to Predict the Onset of COVID-19

Mucosal vaccine platforms offer a broader perspective also for respiratory virus vaccines, such as COVID-19 and influenza

Company announces publication of DARE-BV1 proof-of-concept study for proprietary thermosetting hydrogel formulation of clindamycin phosphate for one-time vaginal administration

Are cancer stem cells a better oncology target?